E
CALC icon

Ergoteles’s CalciMedica CALC Stock Holding History

Ergoteles’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-253
Closed -$96K – 1249
2021
Q2 		$96K Buy
+253
New +$83K ﹤0.01% 1417

Other funds holding CALC

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ergoteles's CALC Position: Q3 2021 in Review

Ergoteles sold out of CalciMedica (CALC) in Q3 2021, closing a stake of 253 shares — an estimated $96K sold.

Ergoteles first reported a position in CALC in Q2 2021 and held it in 1 quarter. The position peaked at $96K in Q2 2021. 26 funds tracked by Wall St. Rank hold CALC as of Q3 2021.

  • Ergoteles reported no remaining CalciMedica position as of Q3 2021 after selling out during the quarter.
  • Ergoteles sold 253 CalciMedica shares in Q3 2021, an estimated $96K.
  • Ergoteles first reported a position in CalciMedica in Q2 2021 and held it in 1 quarter.
  • Ergoteles's CalciMedica position peaked at $96K in Q2 2021.
  • 26 funds tracked by Wall St. Rank held CalciMedica as of Q3 2021.

Based on Ergoteles's 13F filing for Q3 2021, filed 15 Nov 2021.